Evidence map›Paper›PMID 34745090›Full record

ArticleFrontiers in immunology2021

Kynurenic Acid and Its Analogue SZR-72 Ameliorate the Severity of Experimental Acute Necrotizing Pancreatitis.

Zsolt Balla, Eszter Sára Kormányos, Balázs Kui, Emese Réka Bálint, Gabriella Fűr, Erik Márk Orján, Béla Iványi, László Vécsei, Ferenc Fülöp, Gabriella Varga and 11 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Zsolt BallaDepartment of Pathophysiology, University of Szeged, Szeged, Hungary.
Eszter Sára KormányosDepartment of Pathophysiology, University of Szeged, Szeged, Hungary.
Balázs KuiDepartment of Medicine, University of Szeged, Szeged, Hungary.
Emese Réka BálintDepartment of Pathophysiology, University of Szeged, Szeged, Hungary.
Gabriella FűrDepartment of Pathophysiology, University of Szeged, Szeged, Hungary.
Erik Márk OrjánDepartment of Pathophysiology, University of Szeged, Szeged, Hungary.
Béla IványiDepartment of Pathology, University of Szeged, Szeged, Hungary.
László VécseiDepartment of Neurology, Interdisciplinary Excellence Centre, University of Szeged, Szeged, Hungary.
Ferenc FülöpInstitute of Pharmaceutical Chemistry, University of Szeged, Szeged, Hungary.
Gabriella VargaInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
András HarazinInstitute of Biophysics, Biological Research Centre, Szeged, Hungary.
Vilmos TubakCreative Laboratory Ltd., Szeged, Hungary.
Mária A DeliInstitute of Biophysics, Biological Research Centre, Szeged, Hungary.
Csaba PappDepartment of Microbiology, University of Szeged, Szeged, Hungary.
Attila GácserDepartment of Microbiology, University of Szeged, Szeged, Hungary.
Tamara MadácsyDepartment of Medicine, University of Szeged, Szeged, Hungary.
Viktória VengloveczDepartment of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary.
József MaléthDepartment of Medicine, University of Szeged, Szeged, Hungary.
Péter HegyiDepartment of Medicine, University of Szeged, Szeged, Hungary.
Lóránd KissDepartment of Pathophysiology, University of Szeged, Szeged, Hungary.
Zoltán RakonczayDepartment of Pathophysiology, University of Szeged, Szeged, Hungary.
University of Szeged · HUHUN-REN Szegedi Biológiai Kutatóközpont · HUUniversity of Pecs · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathophysiology of acute pancreatitis (AP) is not well understood, and the disease does not have specific therapy. Tryptophan metabolite L-kynurenic acid (KYNA) and its synthetic analogue SZR-72 are antagonists of the N-methyl-D-aspartate receptor (NMDAR) and have immune modulatory roles in several inflammatory diseases. Our aims were to investigate the effects of KYNA and SZR-72 on experimental AP and to reveal their possible mode of action. AP was induced by intraperitoneal (i.p.) injection of L-ornithine-HCl (LO) in SPRD rats. Animals were pretreated with 75-300 mg/kg KYNA or SZR-72. Control animals were injected with physiological saline instead of LO, KYNA and/or SZR-72. Laboratory and histological parameters, as well as pancreatic and systemic circulation were measured to evaluate AP severity. Pancreatic heat shock protein-72 and IL-1β were measured by western blot and ELISA, respectively. Pancreatic expression of NMDAR1 was investigated by RT-PCR and immunohistochemistry. Viability of isolated pancreatic acinar cells in response to LO, KYNA, SZR-72 and/or NMDA administration was assessed by propidium-iodide assay. The effects of LO and/or SZR-72 on neutrophil granulocyte function was also studied. Almost all investigated laboratory and histological parameters of AP were significantly reduced by administration of 300 mg/kg KYNA or SZR-72, whereas the 150 mg/kg or 75 mg/kg doses were less or not effective, respectively. The decreased pancreatic microcirculation was also improved in the AP groups treated with 300 mg/kg KYNA or SZR-72. Interestingly, pancreatic heat shock protein-72 expression was significantly increased by administration of SZR-72, KYNA and/or LO. mRNA and protein expression of NMDAR1 was detected in pancreatic tissue. LO treatment caused acinar cell toxicity which was reversed by 250 µM KYNA or SZR-72. Treatment of acini with NMDA (25, 250, 2000 µM) did not influence the effects of KYNA or SZR-72. Moreover, SZR-72 reduced LO-induced H

Indexed as

AnimalsInterleukin-1betaKynurenic AcidMaleMicrocirculationN-MethylaspartatePancreatitis, Acute NecrotizingPatient AcuityRatsRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateInterleukin-1betaKynurenic AcidN-MethylaspartateReceptors, N-Methyl-D-AspartateSZR 72acute pancreatitiskynurenic acidNMDANMDA receptor-1N-methyl-D-aspartateSZR-72tryptophan pathway

Identifiers

PMID34745090
PMCPMC8567016
OpenAlexW3208617990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.